person · Reporting owner

MCKINNELL HENRY A

Disclosed activity across 5 companies

Tapewire entity: 17327
SEC CIK: 0001174453

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ChemoCentryx, Inc.CCXI · Entity 122928	Director	May 20, 2022	May 24, 2022
MOODYS CORP /DE/MCO · Entity 386	Director	March 18, 2021	March 19, 2021
ViewRay, Inc.VRAY · Entity 111118	Director	January 02, 2019	January 03, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ChemoCentryx, Inc.

Report date May 20, 2022 · Filed May 24, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	72,749	Reported balance After 2022-05-20 transaction · row 1 1 source row Row 1 · 2022-05-20 · Exercise / conversion · Acquired 7,726 · Balance 72,749 F1: Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-05-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-05-20 · Exercise / conversion · Disposed 7,726 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. F3: 100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.

Filing footnotes · ownership attribution and instrument terms

F1: Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.

F2: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F3: 100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.

MOODYS CORP /DE/

Report date March 18, 2021 · Filed March 19, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	89,487.963	Ending reported balance After 2021-03-18 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2021-03-18 · Grant · Acquired 109 · Balance 89,471.388 F1: Restricted Stock deferred dividend reinvestment accrual. Row 2 · 2021-03-18 · Grant · Acquired 16.575 · Balance 89,487.963 F2: RSU deferred dividend reinvestment accrual.
Phantom Stock Units (Deferred Performance Shares)SEC Table II · derivative / convertible security	Direct	1,885.499	Reported balance After 2021-03-18 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-03-18 · Grant · Acquired 4.056 · Balance 1,885.499 F3: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F4: The security converts to common stock on a one-for-one basis. F5: These units are to be settled in stock after the Reporting Person's retirement.
Dividend EquivalentSEC Table II · derivative / convertible security	Direct	1.393	Reported balance After 2021-03-18 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-03-18 · Grant · Acquired 1.393 · Balance 1.393 F6: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock deferred dividend reinvestment accrual.

F2: RSU deferred dividend reinvestment accrual.

F3: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares.

F4: The security converts to common stock on a one-for-one basis.

F5: These units are to be settled in stock after the Reporting Person's retirement.

F6: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award.

ViewRay, Inc.

Report date January 02, 2019 · Filed January 03, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	689,046	Ending reported balance After 2019-01-02 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2019-01-02 · Grant · Acquired 8,928 · Balance 670,378 F1: The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date. F2: These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $55,000. Row 2 · 2019-01-02 · Grant · Acquired 18,668 · Balance 689,046 F3: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date.

F2: These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $55,000.

F3: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Federal Street Acquisition Corp.

Report date January 04, 2019 · Filed January 04, 2019

Section 16 reporting ended · disclosed 2019-01-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative	Direct	0	Ending reported balance After 2019-01-04 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2019-01-04 · Conversion · Acquired 25,000 · Balance 25,000 F1: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date. Row 2 · 2019-01-04 · Disposition to issuer · Disposed 25,000 · Balance 0 F2: In accordance with the Amended and Restated Agreement and Plan of Merger, dated as of December 19, 2018 by and among the Issuer, Agiliti, Inc., Agiliti Holdco, Inc. and the other parties thereto, at the closing of the business combination contemplated thereby, Mr. McKinnell disposed of 25,000 shares of the Issuer's Class A Common Stock in exchange for 25,000 shares of common stock of Agiliti, Inc.
Class F Common Stock, par value $0.0001 per shareSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2019-01-04 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-01-04 · Conversion · Disposed 25,000 · Balance 0 F1: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date.

F2: In accordance with the Amended and Restated Agreement and Plan of Merger, dated as of December 19, 2018 by and among the Issuer, Agiliti, Inc., Agiliti Holdco, Inc. and the other parties thereto, at the closing of the business combination contemplated thereby, Mr. McKinnell disposed of 25,000 shares of the Issuer's Class A Common Stock in exchange for 25,000 shares of common stock of Agiliti, Inc.

PFIZER INC

Report date February 28, 2007 · Filed March 02, 2007

Section 16 reporting ended · disclosed 2007-03-02. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	2,134,851	Reported balance After 2007-02-28 transaction · row 1 1 source row Row 1 · 2007-02-28 · Tax withholding · Disposed 35,309 · Balance 2,134,851
Phantom Stock Units SSPSEC Table II · derivative / convertible security	Direct	100,460	Reported balance After 2007-02-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2007-02-28 · Grant · Acquired 240 · Balance 100,460 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time.
Common StockSEC Table I · non-derivative	IndirectBy Rule 16b-3 Plan	40,894	Reported balance Holding disclosure · report date 2007-02-28 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 40,894
Common StockSEC Table I · non-derivative	IndirectBy Trust	212,688	Reported balance Holding disclosure · report date 2007-02-28 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 212,688

Filing footnotes · ownership attribution and instrument terms

F1: Each unit represents one phantom share of common stock.

F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
January 04, 2019 Filed Jan 4, 2019 19:40 UTC	Federal Street Acquisition Corp. FSAC · Entity 161278	ConversionClass A Common Stock, par value $0.0001 per share	25,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-19-000915 · a4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date. F1 · price: Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of the Issuer's Class F Common Stock, par value $0.0001 per share ("Class F Common Stock"), automatically converted into shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), on a one-for-one basis, on January 4, 2019 at the time of the Issuer's initial business combination. The Class F Common Stock had no expiration date. Read SEC document
January 02, 2019 Filed Jan 3, 2019 20:22 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	18,668	$0.00	$0.00	Disclosure SEC source: 0000950103-19-000202 · ownership.xml · nonDerivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,046 F3 · shares: The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. All of these RSUs shall vest on January 2, 2020 (the one-year anniversary of the grant date), subject to the Reporting Person remaining a service provider through such date. Read SEC document
January 02, 2019 Filed Jan 3, 2019 20:22 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	8,928	$6.16	$54,996.48	Disclosure SEC source: 0000950103-19-000202 · ownership.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670,378 F1 · shares: The reported securities are DSUs that entitle the Reporting Person to receive one share of Common Stock per DSU upon the earliest of (i) the Reporting Person's termination of service from the Issuer's board of directors, (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan or (iii) January 2, 2029 (the tenth anniversary of the grant date). 1/12th of these DSUs shall vest on the last day of each calendar month beginning on January 31, 2019 such that 100% of the DSUs will be vested on December 31, 2019, subject to the Reporting Person remaining a service provider through each such vesting date. F2 · price: These DSUs were issued to the reporting person pursuant to ViewRay Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $55,000. Read SEC document
December 21, 2018 Filed Dec 26, 2018 21:46 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantStock Option (right to buy) · Derivative	19,116	$0.00 Strike: $5.21	$0.00	Disclosure SEC source: 0000950103-18-015066 · dp100064_4-mckinnell.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,116 Underlying: Common Stock · 19,116 shares Expires 2028-12-21 F1 · derivative.exercise_date: All of the shares subject to the option had vested and were exercisable as of December 2018. Read SEC document
December 12, 2018 Filed Dec 13, 2018 23:49 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantDividend Equivalent · Derivative	4.456	$0.00	$0.00	Disclosure SEC source: 0001209191-18-062524 · doc4.xml · derivative · entry 3 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15.722 Underlying: Common Stock · 4.456 shares Expires not disclosed F5 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award Read SEC document
December 12, 2018 Filed Dec 13, 2018 23:49 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	5.455	$148.43	$809.69	Disclosure SEC source: 0001209191-18-062524 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,845.782 Underlying: Common Stock · 5.455 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
December 12, 2018 Filed Dec 13, 2018 23:49 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	153	$149.45	$22,865.85	Disclosure SEC source: 0001209191-18-062524 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,356 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
September 10, 2018 Filed Sep 11, 2018 20:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantDividend Equivalent · Derivative	3.711	$0.00	$0.00	Disclosure SEC source: 0001209191-18-050454 · doc4.xml · derivative · entry 3 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11.266 Underlying: Common Stock · 3.711 shares Expires not disclosed F5 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award Read SEC document
September 10, 2018 Filed Sep 11, 2018 20:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	4.559	$177.16	$807.67	Disclosure SEC source: 0001209191-18-050454 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,840.327 Underlying: Common Stock · 4.559 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
September 10, 2018 Filed Sep 11, 2018 20:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	127	$177.46	$22,537.42	Disclosure SEC source: 0001209191-18-050454 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,203 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
July 02, 2018 Filed Jul 5, 2018 17:46 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	3,160	$7.12	$22,499.20	Disclosure SEC source: 0000950103-18-008369 · dp93192_4-mckinnell.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661,450 F1 · shares: 1/6th of these shares shall vest and become exercisable on the last day of each calendar month beginning on July 31, 2018, such that 100% of the shares will be vested on December 31, 2018, subject to the Reporting Person remaining a service provider through each such vesting date. F2 · price: These shares were issued to the reporting person pursuant to ViewRay, Inc.'s Non-Employee Director Compensation Policy in lieu of retainer and committee service fees of $22,500. Read SEC document
June 11, 2018 Filed Jun 13, 2018 20:04 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantDividend Equivalent · Derivative	3.687	$0.00	$0.00	Disclosure SEC source: 0001209191-18-037440 · doc4.xml · derivative · entry 3 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7.555 Underlying: Common Stock · 3.687 shares Expires not disclosed F5 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award Read SEC document
June 11, 2018 Filed Jun 13, 2018 20:04 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	4.531	$177.82	$805.70	Disclosure SEC source: 0001209191-18-037440 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,835.768 Underlying: Common Stock · 4.531 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
June 11, 2018 Filed Jun 13, 2018 20:04 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	125	$178.50	$22,312.50	Disclosure SEC source: 0001209191-18-037440 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,076 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
May 21, 2018 Filed May 23, 2018 21:49 UTC	ChemoCentryx, Inc. CCXI · Entity 122928	GrantStock Option (Right to buy) · Derivative	13,352	$0.00 Strike: $12.94	$0.00	Disclosure SEC source: 0001209191-18-032800 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,352 Underlying: Common Stock · 13,352 shares Expires 2028-05-21 F3 · derivative.exercise_date: The option was granted on May 21, 2018. The award vests and becomes exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Read SEC document
May 21, 2018 Filed May 23, 2018 21:49 UTC	ChemoCentryx, Inc. CCXI · Entity 122928	GrantRestricted Stock Units · Derivative	8,421	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-18-032800 · doc4.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,421 Underlying: Common Stock · 8,421 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. F2 · derivative.exercise_date: The restricted stock units awarded on May 21, 2018 vests on the first anniversary of the grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. F2 · derivative.expiration_date: The restricted stock units awarded on May 21, 2018 vests on the first anniversary of the grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. Read SEC document
March 12, 2018 Filed Mar 13, 2018 20:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantDividend Equivalent · Derivative	3.868	$0.00	$0.00	Disclosure SEC source: 0001209191-18-019159 · doc4.xml · derivative · entry 3 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3.868 Underlying: Common Stock · 3.868 shares Expires not disclosed F5 · derivative.exercise_price: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.exercise_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award F5 · derivative.expiration_date: Dividend Equivalents accrued on exempt grant of unvested RSUs, which will vest and settle with the underlying award Read SEC document
March 12, 2018 Filed Mar 13, 2018 20:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	4.731	$169.86	$803.61	Disclosure SEC source: 0001209191-18-019159 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,831.237 Underlying: Common Stock · 4.731 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
March 12, 2018 Filed Mar 13, 2018 20:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	129	$170.25	$21,962.25	Disclosure SEC source: 0001209191-18-019159 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,951 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
February 16, 2018 Filed Feb 20, 2018 21:12 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	1,493	$0.00	$0.00	Disclosure SEC source: 0001209191-18-011278 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,822 F1 · shares: Exempt grant of restricted stock units. Read SEC document
December 12, 2017 Filed Dec 13, 2017 21:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	4.538	$152.57	$692.36	Disclosure SEC source: 0001209191-17-065410 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,826.506 Underlying: Common Stock · 4.538 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
December 12, 2017 Filed Dec 13, 2017 21:06 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	124	$153.05	$18,978.20	Disclosure SEC source: 0001209191-17-065410 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,329 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
November 15, 2017 Filed Apr 25, 2018 17:04 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantStock Option (right to buy) · Derivative	45,633	$0.00 Strike: $8.02	$0.00	Disclosure SEC source: 0000950103-18-005160 · dp89956_4-mckinnell.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,633 Underlying: Common Stock · 45,633 shares Expires 2027-11-15 F3 · derivative.exercise_date: 27,174 of the shares subject to the option were fully vested on November 15, 2017. 1/12 of the remaining 18,459 shares subject to the option vested and became exercisable on each monthly anniversary measured from June 19, 2017, such that 100% of the shares subject to the option will fully vest on June 19, 2018. Read SEC document
November 15, 2017 Filed Apr 25, 2018 17:04 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	4,987	$0.00	$0.00	Disclosure SEC source: 0000950103-18-005160 · dp89956_4-mckinnell.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,290 F1 · shares: The reported securities are fully vested RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon the earlier of (i) the Reporting Person's termination of service from the Issuer's board of directors or (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan. F2 · balance_after: Includes 10,573 Restricted Stock Units. Read SEC document
September 12, 2017 Filed Sep 13, 2017 20:05 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	5.071	$136.16	$690.47	Disclosure SEC source: 0001209191-17-052579 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,821.968 Underlying: Common Stock · 5.071 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
September 12, 2017 Filed Sep 13, 2017 20:05 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	140	$135.52	$18,972.80	Disclosure SEC source: 0001209191-17-052579 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,205 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
June 12, 2017 Filed Jun 13, 2017 20:02 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	5.872	$117.19	$688.14	Disclosure SEC source: 0001209191-17-039425 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,816.897 Underlying: Common Stock · 5.872 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
June 12, 2017 Filed Jun 13, 2017 20:02 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	162	$116.95	$18,945.90	Disclosure SEC source: 0001209191-17-039425 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,065 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
May 25, 2017 Filed May 30, 2017 19:09 UTC	ChemoCentryx, Inc. CCXI · Entity 122928	GrantCommon Stock	12,912	$0.00	$0.00	Disclosure SEC source: 0001209191-17-036273 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,218 F1 · shares: The restricted stock was awarded on May 25, 2017, and 100% of the restricted stock will vest on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. Read SEC document
March 10, 2017 Filed Mar 13, 2017 20:04 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	6.128	$111.93	$685.91	Disclosure SEC source: 0001209191-17-020137 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,811.025 Underlying: Common Stock · 6.128 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
March 10, 2017 Filed Mar 13, 2017 20:04 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	161	$112.18	$18,060.98	Disclosure SEC source: 0001209191-17-020137 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,903 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
February 27, 2017 Filed Feb 28, 2017 21:04 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	2,142	$0.00	$0.00	Disclosure SEC source: 0001209191-17-015225 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,742 F1 · shares: Exempt grant of restricted stock. Read SEC document
January 18, 2017 Filed Jan 20, 2017 16:34 UTC	ViewRay, Inc. VRAY · Entity 111118	PurchaseWarrant to Purchase Common Stock · Derivative	62,597	$0.13 Strike: $3.17	$7,824.63	Disclosure SEC source: 0001140361-17-002417 · doc1.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,597 Underlying: Common Stock · 62,597 shares Expires 2024-01-18 Read SEC document
January 18, 2017 Filed Jan 20, 2017 16:34 UTC	ViewRay, Inc. VRAY · Entity 111118	PurchaseCommon Stock	312,989	$3.17	$992,175.13	Disclosure SEC source: 0001140361-17-002417 · doc1.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,303 F1 · balance_after: Includes 5,586 Restricted Stock Units. Read SEC document
December 12, 2016 Filed Dec 13, 2016 21:03 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	6.77	$98.27	$665.29	Disclosure SEC source: 0001209191-16-154884 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,804.897 Underlying: Common Stock · 6.77 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
December 12, 2016 Filed Dec 13, 2016 21:03 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	177	$98.21	$17,383.17	Disclosure SEC source: 0001209191-16-154884 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,036 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
November 03, 2016 Filed Nov 7, 2016 19:03 UTC	ChemoCentryx, Inc. CCXI · Entity 122928	OtherRestricted Stock Units · Derivative	30,120	$0.00	$0.00	Disclosure SEC source: 0001209191-16-148741 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,120 shares Expires not disclosed F2 · derivative.exercise_price: On October 17, 2016, the Reporting Person received restricted stock units from the Issuer. This grant of restricted stock units was rescinded and a replacement restricted stock award was granted on November 3, 2016. F2 · kind: On October 17, 2016, the Reporting Person received restricted stock units from the Issuer. This grant of restricted stock units was rescinded and a replacement restricted stock award was granted on November 3, 2016. F2 · derivative.exercise_date: On October 17, 2016, the Reporting Person received restricted stock units from the Issuer. This grant of restricted stock units was rescinded and a replacement restricted stock award was granted on November 3, 2016. F2 · derivative.expiration_date: On October 17, 2016, the Reporting Person received restricted stock units from the Issuer. This grant of restricted stock units was rescinded and a replacement restricted stock award was granted on November 3, 2016. Read SEC document
November 03, 2016 Filed Nov 7, 2016 19:03 UTC	ChemoCentryx, Inc. CCXI · Entity 122928	GrantCommon Stock	31,306	$0.00	$0.00	Disclosure SEC source: 0001209191-16-148741 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,306 F1 · shares: The restricted stock was awarded on November 3, 2016 and vests in three equal installments on October 17, 2017, October 17, 2018 and October 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. Read SEC document
October 17, 2016 Filed Oct 19, 2016 19:09 UTC	ChemoCentryx, Inc. CCXI · Entity 122928	GrantRestricted Stock Units · Derivative	30,120	$0.00	$0.00	Disclosure SEC source: 0001209191-16-146408 · doc4.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,120 Underlying: Common Stock · 30,120 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock. F2 · derivative.exercise_date: The restricted stock units were awarded on October 17, 2017 and vest in three equal installments on October 17, 2017, October 17, 2018 and October 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. F2 · derivative.expiration_date: The restricted stock units were awarded on October 17, 2017 and vest in three equal installments on October 17, 2017, October 17, 2018 and October 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date. Read SEC document
September 13, 2016 Filed Sep 15, 2016 20:32 UTC	ViewRay, Inc. VRAY · Entity 111118	GrantCommon Stock	5,586	$0.00	$0.00	Disclosure SEC source: 0001140361-16-079956 · doc1.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,314 F1 · shares: Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon vesting. 100% of the RSUs shall be fully vested as of the date of grant, however, delivery of the shares will be deferred until the earlier of (i) the Reporting Person's termination of service from the Issuer's board of directors or (ii) a Change of Control of the Issuer as defined in the Issuer's 2015 Equity Incentive Award Plan. Read SEC document
September 12, 2016 Filed Sep 13, 2016 20:03 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantPhantom Stock Units (Deferred Performance Shares) · Derivative	6.105	$108.61	$663.06	Disclosure SEC source: 0001209191-16-141127 · doc4.xml · derivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,798.127 Underlying: Common Stock · 6.105 shares Expires not disclosed F2 · security: Phantom stock units arising out of the Reporting Person's election to defer receipt of earned performance shares. F3 · derivative.exercise_price: The security converts to common stock on a one-for-one basis. F4 · derivative.exercise_date: These units are to be settled in stock after the Reporting Person's retirement. F4 · derivative.expiration_date: These units are to be settled in stock after the Reporting Person's retirement. Read SEC document
September 12, 2016 Filed Sep 13, 2016 20:03 UTC	MOODYS CORP /DE/ MCO · Entity 386	GrantCommon Stock	162	$106.48	$17,249.76	Disclosure SEC source: 0001209191-16-141127 · doc4.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,859 F1 · shares: Restricted Stock deferred dividend reinvestment accrual. Read SEC document
August 05, 2016 Filed Feb 10, 2017 21:02 UTC	MOODYS CORP /DE/ MCO · Entity 386	GiftCommon Stock	40,436	$0.00	$0.00	Disclosure SEC source: 0001209191-17-009513 · doc5.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,600 F1 · shares: These shares were gifted to a charitable foundation that is controlled by the reporting person. Effective upon such transfer, the reporting person ceased to have a beneficial pecuniary interest in such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document
February 28, 2007 Filed Mar 2, 2007 20:22 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	240	$24.96	$5,990.40	Disclosure SEC source: 0000078003-07-000037 · mck1438.xml · derivative · entry 4 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,460 Underlying: Common Stock · 240 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
February 28, 2007 Filed Mar 2, 2007 20:22 UTC	PFIZER INC PFE · Entity 2863	Tax withholdingCommon Stock	35,309	$24.96	$881,312.64	Disclosure SEC source: 0000078003-07-000037 · mck1438.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,134,851 Read SEC document
February 22, 2007 Filed Feb 26, 2007 22:12 UTC	PFIZER INC PFE · Entity 2863	GrantCommon Stock	198,000	$0.00	$0.00	Disclosure SEC source: 0000078003-07-000030 · mck1437.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,170,160 F1 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document
February 15, 2007 Filed Feb 16, 2007 20:41 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	1,165	$26.53	$30,907.45	Disclosure SEC source: 0000078003-07-000023 · mck1427.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,220 Underlying: Common Stock · 1,165 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document
January 29, 2007 Filed Jan 30, 2007 16:48 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	5,448	$0.00 Strike: $18.35	$0.00	Disclosure SEC source: 0000078003-07-000016 · mck1420.xml · derivative · entry 4 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,552 Underlying: Common Stock · 5,448 shares Expires 2007-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 28,1998. Read SEC document
January 29, 2007 Filed Jan 30, 2007 16:48 UTC	PFIZER INC PFE · Entity 2863	Exercise / conversionCommon Stock	5,448	$18.35	$99,970.80	Disclosure SEC source: 0000078003-07-000016 · mck1420.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,971,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 29, 2006 Filed Jan 3, 2007 23:26 UTC	PFIZER INC PFE · Entity 2863	GrantPhantom Stock Units SSP · Derivative	154	$25.90	$3,988.60	Disclosure SEC source: 0000078003-07-000010 · mck1410.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,099 Underlying: Common Stock · 154 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.